Gabay Avraham - Insider Non-Derivative Transactions at ORAMED PHARMACEUTICALS INC. (ORMP) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Feb 11, 2025, Gabay Avraham's relationship to ORAMED PHARMACEUTICALS INC. (ORMP) is Officer (Chief Financial Officer), and currently has 434,040 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ORMP insiders.

Related Topics: SEC Topic List.
Data Source: SEC.
Gabay Avraham - Insider Non-Derivative Transactions of ORMP Common Stock
Gabay Avraham - Insider Non-Derivative Transactions at ORMP
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Feb 12, 2025 Acquisition -- (Common Stock) 34000 0 392040
Feb 12, 2025 Acquisition -- (Common Stock) 42000 0 434040
Jan 3, 2025 Acquisition -- (Common Stock) 188000 0 358040
Nov 8, 2024 Acquisition -- (Common Stock) 30000 0 170040
Jun 22, 2024 Acquisition -- (Common Stock) 140040 0 0